Health Catalyst Inc (HCAT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Health Catalyst Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 13 | $60 | $37 | $46.69 | $48.58 | -3.89% |
The Trend in the Analyst Price Target
HCAT's average price target has moved up $3.37 over the prior 150 days.
HCAT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 7 | 7 | 0 | 0 | 0 | 14 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HCAT as an investment opportunity.
- Health Catalyst Inc's number of analysts covering the stock is higher than 81% of all US stocks.
- Health Catalyst Inc's average analyst price target is higher than 83.2% of stocks in the small market cap category.
- The variance in analysts' estimates of HCAT is less than 23.3% of stocks in the small market cap category.
- The upside potential (average analyst target price relative to current price) of HCAT is higher than 24.82% of stocks in the small market cap category.
- The NA of HCAT is higher than practically none of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Business Services industry with the ratings most similar to Health Catalyst Inc are NEO, TENB and SPT.
Is HCAT a Buy, Hold or Sell? See the POWR Ratings now!